ライブラリ登録: Guest
Journal of Environmental Pathology, Toxicology and Oncology

年間 4 号発行

ISSN 印刷: 0731-8898

ISSN オンライン: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

Immune Response Against Angiosarcoma Following Lower Fluence Rate Clinical Photodynamic Therapy

巻 27, 発行 1, 2008, pp. 35-42
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i1.40
Get accessGet access

要約

Tumor response to photodynamic therapy (PDT) is dependent on treatment parameters used. In particular, the light fluence rate may be an important determinant of the treatment outcome. In this clinical case report, we describe the response of angiosarcoma to PDT carried out using different fluence rates and drug and light doses. A patient with recurrent multifocal angiosarcoma of the head and neck was recruited for PDT. A new generation chlorin-based photosensitizer, Fotolon, was administered at a dose of 2.0 to 5.7 mg/kg. The lesions were irradiated with 665 nm laser light for a light dose of 65 to 200 J/cm2 delivered at a fluence rate of 80 or 150 mW/cm2. High dose PDT carried out at a high fluence rate resulted in local control of the disease for up to a year; however, the disease recurred and PDT had to be repeated. PDT of new lesions carried out at a lower fluence rate resulted in tumor eradication. More significantly, it also resulted in spontaneous remission of neighboring and distant untreated lesions. Repeat PDT carried out on a recurrent lesion at a lower fluence rate resulted in eradication of both treated and untreated lesions despite the lower total light dose delivered. Immunohistochemical examination of biopsy samples implies that PDT could have activated a cell-mediated immune response against untreated lesions. Subsequent histopatho-logical examination of the lesion sites showed negative for disease. Our clinical observations show that lower fluence rate PDT results in better outcome and also indicate that the fluence rate, rather than the total light dose, is a more crucial determinant of the treatment outcome. Specifically, lower fluence rate PDT appears to activate the body's immune response against untreated lesions.

によって引用された
  1. Huang Ying-Ying, Tanaka Masamitsu, Vecchio Daniela, Garcia-Diaz Maria, Chang Julie, Morimoto Yuji, Hamblin Michael R, Photodynamic therapy induces an immune response against a bacterial pathogen, Expert Review of Clinical Immunology, 8, 5, 2012. Crossref

  2. Kushibiki Toshihiro, Hirasawa Takeshi, Okawa Shinpei, Ishihara Miya, Responses of Cancer Cells Induced by Photodynamic Therapy, Journal of Healthcare Engineering, 4, 1, 2013. Crossref

  3. Gollnick Sandra O., Brackett Craig M., Enhancement of anti-tumor immunity by photodynamic therapy, Immunologic Research, 46, 1-3, 2010. Crossref

  4. Olivo Malini, Bhuvaneswari Ramaswamy, Lucky Sasidharan Swarnalatha, Dendukuri Nagamani, Soo-Ping Thong Patricia, Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities, Pharmaceuticals, 3, 5, 2010. Crossref

  5. Gollnick Sandra, Mechanistic Principles of Photodynamic Therapy, in Biomedical Photonics Handbook, Second Edition, 2014. Crossref

  6. Busch Theresa M., Wang Hsing-Wen, Wileyto E. Paul, Yu Guoqiang, Bunte Ralph M., Increasing Damage to Tumor Blood Vessels during Motexafin Lutetium-PDT through Use of Low Fluence Rate, Radiation Research, 174, 3, 2010. Crossref

  7. Ding Hui, Lv Yanlin, Ni Dezhi, Wang Jie, Tian Zhiyuan, Wei Wei, Ma Guanghui, Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer, Nanoscale, 7, 21, 2015. Crossref

  8. Anzengruber Florian, Avci Pinar, de Freitas Lucas Freitas, Hamblin Michael R., T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?, Photochemical & Photobiological Sciences, 14, 8, 2015. Crossref

  9. Bredell Marius G., Besic Emina, Maake Caroline, Walt Heinrich, The application and challenges of clinical PD–PDT in the head and neck region: A short review, Journal of Photochemistry and Photobiology B: Biology, 101, 3, 2010. Crossref

  10. Lucky Sasidharan Swarnalatha, Muhammad Idris Niagara, Li Zhengquan, Huang Kai, Soo Khee Chee, Zhang Yong, Titania Coated Upconversion Nanoparticles for Near-Infrared Light Triggered Photodynamic Therapy, ACS Nano, 9, 1, 2015. Crossref

  11. Agostinis Patrizia, Berg Kristian, Cengel Keith A., Foster Thomas H., Girotti Albert W., Gollnick Sandra O., Hahn Stephen M., Hamblin Michael R., Juzeniene Asta, Kessel David, Korbelik Mladen, Moan Johan, Mroz Pawel, Nowis Dominika, Piette Jacques, Wilson Brian C., Golab Jakub, Photodynamic therapy of cancer: An update, CA: A Cancer Journal for Clinicians, 61, 4, 2011. Crossref

  12. Belicha-Villanueva Alan, Riddell Jonah, Bangia Naveen, Gollnick Sandra O., The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules, Lasers in Surgery and Medicine, 44, 1, 2012. Crossref

  13. Weiss Andrea, den Bergh Hubert van, Griffioen Arjan W., Nowak-Sliwinska Patrycja, Angiogenesis inhibition for the improvement of photodynamic therapy: The revival of a promising idea, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1826, 1, 2012. Crossref

  14. Yeo Eugenia Li Ling, Cheah Joshua U-Jin, Neo Dawn Jing Hui, Goh Wah Ing, Kanchanawong Pakorn, Soo Khee Chee, Thong Patricia Soo Ping, Kah James Chen Yong, Exploiting the protein corona around gold nanorods for low-dose combined photothermal and photodynamic therapy, Journal of Materials Chemistry B, 5, 2, 2017. Crossref

  15. Maeding Nicole, Verwanger Thomas, Krammer Barbara, Boosting Tumor-Specific Immunity Using PDT, Cancers, 8, 10, 2016. Crossref

  16. Hamblin Michael Richard, Sabino Caetano Padial, Systemic Effects, in Photodynamic Therapy in Veterinary Medicine: From Basics to Clinical Practice, 2016. Crossref

  17. Hamblin Michael R., Photodynamic Therapy and Photobiomodulation: Can All Diseases be Treated with Light?, in Encyclopedia of Modern Optics, 2018. Crossref

  18. Gallagher‐Colombo Shannon M., Finlay Jarod C., Busch Theresa M., Tumor Microenvironment as a Determinant of Photodynamic Therapy Resistance, in Resistance to Photodynamic Therapy in Cancer, 5, 2015. Crossref

  19. Liu Dihui, Li Bin, Shi Wei, Chen Xiang, Zhao Shuang, A case report of cutaneous angiosarcoma treated by photodynamic therapy with chemotherapy and surgery, Photodiagnosis and Photodynamic Therapy, 25, 2019. Crossref

  20. Hameed Sadaf, Mo Shanyan, Mustafa Ghulam, Bajwa Sadia Z., Khan Waheed S., Dai Zhifei, Immunological Consequences of Nanoparticle‐Mediated Antitumor Photoimmunotherapy, Advanced Therapeutics, 3, 5, 2020. Crossref

  21. Wilson Brian C., Weersink Robert A., The Yin and Yang of PDT and PTT, Photochemistry and Photobiology, 96, 2, 2020. Crossref

  22. Yue Dong, Cai Xiaojun, Fan Mengni, Zhu Jingwu, Tian Jiang, Wu Lihuang, Jiang Qian, Gu Zhongwei, An Alternating Irradiation Strategy‐Driven Combination Therapy of PDT and RNAi for Highly Efficient Inhibition of Tumor Growth and Metastasis, Advanced Healthcare Materials, 10, 8, 2021. Crossref

  23. Hamblin Michael R., Abrahamse Heidi, Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response, Anti-Cancer Agents in Medicinal Chemistry, 21, 2, 2020. Crossref

  24. Chin William WL, Thong Patricia SP, Bhuvaneswari Ramaswamy, Soo Khee Chee, Heng Paul WS, Olivo Malini, In-vivo optical detection of cancer using chlorin e6 – polyvinylpyrrolidone induced fluorescence imaging and spectroscopy, BMC Medical Imaging, 9, 1, 2009. Crossref

  25. Kabingu Edith, Oseroff Allan R., Wilding Gregory E., Gollnick Sandra O., Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy, Clinical Cancer Research, 15, 13, 2009. Crossref

  26. Roque III John A., Cole Houston D., Barrett Patrick C., Lifshits Liubov M., Hodges Rachel O., Kim Susy, Deep Gagan, Francés-Monerris Antonio, Alberto Marta E., Cameron Colin G., McFarland Sherri A., Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia, Journal of the American Chemical Society, 144, 18, 2022. Crossref

  27. Muchowicz Angelika, Wachowska Malgorzata, Stachura Joanna, Tonecka Katarzyna, Gabrysiak Magdalena, Wołosz Dominika, Pilch Zofia, Kilarski Witold W., Boon Louis, Klaus Tomasz J., Golab Jakub, Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice, European Journal of Cancer, 83, 2017. Crossref

  28. Long Shan, Zhao Yibing, Xu Yuanyuan, Li Hui, Zhao Hongyou, Chen Defu, Zeng Jing, Qiu Haixia, Li Xiaosong, Gu Ying, Immune response induced by hematoporphyrin derivatives mediated photodynamic therapy: Immunogenic cell death and elevated costimulatory molecules, Journal of Innovative Optical Health Sciences, 15, 04, 2022. Crossref

713 記事の閲覧数 28 記事のダウンロード 記事の統計
713 記事の閲覧数 28 記事のダウンロード 28 Crossref 引用数 Google
Scholar
引用数

類似内容の記事:

MASS BALANCE OF NEBULIZED DRUG DELIVERY: RESIDUAL DRUG LEVELS AND THE EFFECTS OF AN ALTERNATIVE AIR HUMIDIFICATION METHOD Atomization and Sprays, Vol.18, 2008, issue 6
Corinne S. Lengsfeld, Benjamen A. Filas
Minimally Invasive Approaches to Inguinal Hernia Repair Journal of Long-Term Effects of Medical Implants, Vol.20, 2010, issue 2
Dennis Leung, Michael B. Ujiki
The Role of Melanin in Skin Cancer Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 1
Muhammad Imran Qadir, Sidra Anwar, Khizar Abbas
Updated Results of a Phase I Trial of Motexafin Lutetium-Mediated Interstitial Photodynamic Therapy in Patients with Locally Recurrent Prostate Cancer Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 1-2
Eli Glatstein, Andreea Dimofte, Kosmas Verigos, Stephen M. Hahn, Zelig A. Tochner, Jarod Finlay, Richard Whittington, Debbie Smith, Theresa M. Busch, Rosemarie Mick, Diana C. Hsiung Stripp, S. Bruce Malkowicz, Timothy C. Zhu
Photodynamic Therapy of Nodular Basal Cell Carcinoma with Multifiber Contact Light Delivery Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 1-2
A. Derjabo, Unne Stenram, Stefan Andersson-Engels, Marcelo Soto Thompson, T. Johansson, J. Spigulis, Sune Svanberg, Sara Palsson, Katarina Svanberg, Niels Bendsoe, J. Kapostins
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain